Skip to contentSkip to Braille Studio

Library / Laws / 118th Congress / Senate Bills / S. 526

S. 526

To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.

Print stageDateSize⠃
Introduced in Senate2023-02-161.3K⠃⠗⠋